Using Population Pharmacokinetic and Pharmacodynamic Analyses of Entecavir in Pediatric Subjects to Simplify Dosing Recommendations

被引：0
|
作者：
Phyllis Chan
Diane R. Mould
Malaz Abu Tarif
Laurie Reynolds
Frank LaCreta
Richard Bertz
Marc Bifano
机构：
[1] Bristol-Myers Squibb,
[2] Projections Research,undefined
[3] Inc.,undefined
来源：
Clinical Pharmacokinetics | 2016年 / 55卷
关键词：
Lamivudine; Entecavir; Visual Predictive Check; Pediatric Subject; Baseline Viral Load;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1559 / 1572
页数：13
相关论文
共 50 条
  • [41] Ribavirin dosing in chronic hepatitis C: Application of population pharmacokinetic-pharmacodynamic models
    Jen, J
    Laughlin, M
    Chung, C
    Heft, S
    Affrime, MB
    Gupta, SK
    Glue, P
    Hajian, G
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 72 (04) : 349 - 361
  • [42] Retrospective population pharmacokinetic analysis of levetiracetam in children and adolescents with epilepsy: Dosing recommendations
    Toublanc, Nathalie
    Sargentini-Maier, Maria Laura
    Lacroix, Brigitte
    Jacqmin, Philippe
    Stockis, Armel
    CLINICAL PHARMACOKINETICS, 2008, 47 (05) : 333 - 341
  • [43] Oral and Intravenous Amoxicillin Dosing Recommendations in Neonates: A Pooled Population Pharmacokinetic Study
    Keij, Fleur M.
    Schouwenburg, Stef
    Kornelisse, Rene F.
    Preijers, Tim
    Mir, Fatima
    Degraeuwe, Pieter
    Stolk, Leo M.
    van Driel, Arianne
    Kenter, Sandra
    van der Sluijs, Jacqueline
    Heidema, Jojanneke
    den Butter, Paul C. P.
    Reiss, Irwin K. M.
    Allegaert, Karel
    Tramper-Stranders, Gerdien A.
    Koch, Birgit C. P.
    Flint, Robert B.
    CLINICAL INFECTIOUS DISEASES, 2023, 77 (11) : 1595 - 1603
  • [44] Population Pharmacokinetic/Pharmacodynamic Modeling of Depot Testosterone Cypionate in Healthy Male Subjects
    Bi, Youwei
    Perry, Paul J.
    Ellerby, Michael
    Murry, Daryl J.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2018, 7 (04): : 259 - 268
  • [45] Population pharmacokinetic and pharmacodynamic model of propofol externally validated in Korean elderly subjects
    Kyung Mi Kim
    Byung-Moon Choi
    Gyu-Jeong Noh
    Journal of Pharmacokinetics and Pharmacodynamics, 2023, 50 : 97 - 109
  • [46] Population pharmacokinetic and pharmacodynamic model of propofol externally validated in Korean elderly subjects
    Kim, Kyung Mi
    Choi, Byung-Moon
    Noh, Gyu-Jeong
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2023, 50 (02) : 97 - 109
  • [47] Population Pharmacokinetic/Pharmacodynamic Analysis of Intravenous Zanamivir in Healthy and Hospitalized Subjects with Influenza
    Zuo, Peiying
    Collins, Jon
    Shortino, Denise
    Watson, Helen
    Roberts, Grace
    Peppercorn, Amanda
    Hossain, Mohammad
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2016, 43 : S112 - S112
  • [48] Population pharmacokinetic-based dosing of intravenous busulfan in pediatric patients
    Booth, Brian P.
    Rahman, Atiqur
    Dagher, Ramzi
    Griebel, Donna
    Lennon, Shari
    Fuller, David
    Sahajwalla, Chandra
    Mehta, Mehul
    Gobburu, Jogarao V. S.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (01): : 101 - 111
  • [49] Population pharmacokinetic and pharmacodynamic analyses of teicoplanin in Japanese patients with systemic MRSA infection
    Ogawa, Ryuichi
    Kobayashi, Seiichi
    Sasaki, Yuki
    Makimura, Mizue
    Echizen, Hirotoshi
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2013, 51 (05) : 357 - 366
  • [50] Guidelines for the Quality Control of Population Pharmacokinetic-Pharmacodynamic Analyses: an Industry Perspective
    Bonate, P. L.
    Strougo, A.
    Desai, A.
    Roy, M.
    Yassen, A.
    van der Walt, J. S.
    Kaibara, A.
    Tannenbaum, S.
    AAPS JOURNAL, 2012, 14 (04): : 749 - 758
12345